Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 20:6:5879.
doi: 10.1038/ncomms6879.

Total synthesis of periploside A, a unique pregnane hexasaccharide with potent immunosuppressive effects

Affiliations

Total synthesis of periploside A, a unique pregnane hexasaccharide with potent immunosuppressive effects

Xiaheng Zhang et al. Nat Commun. .

Abstract

Periploside A is a pregnane hexasaccharide identified from the Chinese medicinal plant Periploca sepium, which features a unique seven-membered formyl acetal bridged orthoester (FABO) motif and potent immunosuppressive activities. Here, we show the synthesis of this molecule in a total of 76 steps with the longest linear sequence of 29 steps and 9.2% overall yield. The FABO motif is constructed via a combination of Sinaÿ's and Crich's protocol for the formation of orthoester and acetal glycosides, respectively. The 2-deoxy-β-glycosidic linkages are assembled stereoselectively with judicious choice of the glycosylation methods. The epimer at the spiro-quaternary carbon in the FABO motif has also been elaborated in a stereo-controlled manner. This epimer, as well as the synthetic analogues bearing the FABO motif, retain largely the inhibitory activities of periploside A against the proliferation of T-lymphocyte, indicating the importance of the chemical connection of the FABO motif to their immunosuppressive activity.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Periploside A 1 and the retrosynthetic analysis.
Shadowed in pale blue are the FABO motifs that have been previously assigned; highlighted in red are leaving groups in donors and in blue are hydroxyl groups in acceptors. Ac, acetyl; CA, chloroacetyl; MP, 4-methoxyphenyl; TBDPS, tert-butyldiphenylsilyl; TBS, tert-butyldimethylsilyl.
Figure 2
Figure 2. Synthesis of tetrasaccharide donor 2.
Highlighted in red are the nascent glycosidic bonds. (a) Ph3PAuNTf2 (0.1 equiv), toluene, 4 Å MS, −40 °C; 95% and β only (for 12); 99% and β only (for 14 and 16); (b) TBAF, THF, 0 °C to RT; 99% (from 12); 94% (from 14); 96% (from 16); (c) CH3(OMe)3, p-TsOH, RT, 93% for (13); 91% (for 15); (d) nBu2SnO, MeOH, reflux; (e) BnBr, DMF, CsF, RT; (f) LiOH, THF, H2O, RT; 87% (for three steps); (g) MeI, NaH, DMF, 0 °C to RT, 99%; (h) Pd(OH)2/C, H2 (1 atm), Et3N, EtOAc, MeOH, 50 °C, 93%; (i) Ph3PAuNTf2 (0.2 equiv), toluene, 5 Å MS, −50 °C to RT, 93%, β/α=4/1; (j) Ag(DPAH)2, CH3CN, H2O, 0 °C to RT, 95%; (k) o-cyclopropylethynylbenzoic acid, EDCI, DMAP, 4 Å MS, CH2Cl2, RT, 99%. DMAP, 4,4-dimethylaminopyridine; DPAH, bis(hydrogen dipicolinate); EDCI, N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride; MS, molecular sieves; TBAF, tetrabutylammonium fluoride.
Figure 3
Figure 3. Construction of the FABO motif and synthesis of C1′′-epi-periploside A (31).
Highlighted in red are the nascent glycosidic bonds. (a) PhSeCl, CH3CN, −40 °C, 78%; (b) DAST, THF, −30 °C to RT; (c) PhSCH2OH, SnCl2, CH2Cl2, 4 Å MS, −40 °C to RT; 58% (for two steps); (d) NIS, TfOH, CH2Cl2, −30 °C, 75% (for 24), 20% (for 23); (e) MeONa, MeOH, CH2Cl2, RT, 93%; (f) NaIO4, NaHCO3, MeOH, CH2Cl2, H2O, RT, 99%; (g) vinyl acetate, toluene, DIPA, Mw, 145 °C, 20 min, 85%; (h) BzCl, Et3N, DMAP, CH2Cl2, 0 °C to RT, 99%; (i) Ag(DPAH)2, CH3CN, H2O, 0 °C to RT, 90%; (j) N-phenyl-2,2,2-trifluoroacetimidoyl chloride, Cs2CO3, CH2Cl2, RT, 95%; (k) TBSOTf, CH2Cl2, 5 Å MS, −78 °C, 85%, β/α=3/1; (l) Et3B, Bu3SnH, toluene, RT, 97%; (m) MeONa, MeOH, CH2Cl2, RT, 99%; (n) Ph3PAuOTf (0.8 equiv), TTBP, CH2Cl2, 4 Å MS, −20 °C to −10 °C, 64% (87% b.r.s.m.), β/α=2.1/1; (o) thiourea, pyridine, EtOH, 80 °C; (p) HF·py, pyridine; THF, 0 °C to RT; 91% (for two steps). DAST, (diethylamino)sulfur trifluoride; DIPA, diisopropylamine; TBSOTf, tert-butyldimethylsilyl trifluoromethane sulfonate; Mw, microwave; TTBP, 2,4,6-tri-tert-butylpyrimidine.
Figure 4
Figure 4. Construction of the FABO motif with the natural configuration.
Highlighted in red are the nascent glycosidic bonds. (a) DAST, THF, −30 °C to RT; (b) SnCl2, Et2O, 4 Å MS, 0 °C to RT; 85% (for two steps); (c) NaIO4, NaHCO3, MeOH, CH2Cl2, H2O, RT, 99%; (d) vinyl acetate, toluene, DIPA, Mw, 140 °C, 40 min, 92%; (e) EtSCH2OH, DCCl3, Mw, 10 min, 110 °C, 81%; (f) H2NNH2·H2O, pyridine, HOAc, 0 °C to RT, 92%; (g) BSP, Tf2O, DTBP, 5 Å MS, Et2O, −114 °C, 64% (for 37), 18% (for 38). BSP, 1-benzenesulfinyl piperidine; DTBP, 2,6-di-tert-butylpyridine; Lev, levuloyl; Mw, microwave.
Figure 5
Figure 5. Completion of the total synthesis of periploside A (1).
Highlighted in red are the nascent glycosidic bonds. (a) Ag(DPAH)2, CH3CN, H2O, 0 °C, 91%; (b) N-phenyl-trifluoroacetimidoyl chloride, Cs2CO3, CH2Cl2, RT, 90%; (c) TBSOTf, CH2Cl2, 5 Å MS, −78 °C, 87%, β/α=6.1/1; (d) Et3B, Bu3SnH, toluene, RT, 95%; (e) MeONa, MeOH, CH2Cl2, RT, 96%; (f) Ph3PAuOTf (0.8 equiv), TTBP, CH2Cl2, 4 Å MS, −10 °C, 80%, β/α=2/1; (g) thiourea, pyridine, EtOH, 80 °C; (h) HF·py, pyridine, THF, 0 °C to RT, 93% (for two steps).
Figure 6
Figure 6. Synthetic analogues of periplosides.
Shadowed in pale blue are the carbon centres with opposite configurations to those in the nature product.

References

    1. Oshima Y., Hirota T. & Hikino H. Periplosides A, B and C, steroidal glycosides of Periploca sepium root barks. Heterocycles 26, 2093–2098 (1987).
    1. Itokawa H. et al. Studies on chemical constituents of antitumor fraction from Periploca sepium. II. Structures of new pregnane glycosides, periplocosides A, B and C. Chem. Pharm. Bull. 36, 982–987 (1988). - PubMed
    1. Itokawa H. et al. Studies on chemical constituents of antitumor fraction from Periploca sepium. IV. Structures of new pregnane glycosides, periplocosides D, E, L and M. Chem. Pharm. Bull. 36, 2084–2089 (1988). - PubMed
    1. Itokawa H. et al. Studies on chemical constituents of antitumor fraction from Periploca sepium. V. Structures of new pregnane glycosides, periplocosides J, K, F and O. Chem. Pharm. Bull. 36, 4441–4446 (1988). - PubMed
    1. Feng J. Q. et al. Immunosuppressive pregnane glycosides from Periploca sepium and Periploca forrestii. Phytochemistry 69, 2716–2723 (2008). - PubMed

Publication types